Belle Mead, NJ, United States of America

Marites A Rafanan

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Ptc Therapeutics, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marites A Rafanan. Retrieved from https://idiyas.com/inventor/marites-a-rafanan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marites A Rafanan: Innovator in Protein Expression Modulation

Introduction

Marites A Rafanan is a notable inventor based in Belle Mead, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of protein expression modulation. Her work has implications for various therapeutic applications.

Latest Patents

Marites holds a patent for BMI-1 protein expression modulators. This patent includes compounds having a specific formula, which are designed to inhibit Bmi-1 expression. The pharmaceutical compositions and methods associated with these compounds are crucial for advancing treatment options in related medical fields.

Career Highlights

Marites is currently employed at PTC Therapeutics, Inc., where she continues to innovate and develop new therapeutic solutions. Her expertise in protein modulation has positioned her as a key figure in her organization and the broader scientific community.

Collaborations

Throughout her career, Marites has collaborated with esteemed colleagues, including Young-Choon Moon and Nadiya Sydorenko. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Marites A Rafanan's contributions to protein expression modulation exemplify her dedication to advancing biotechnology. Her innovative work continues to impact the field and offers promising avenues for future research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…